AKT1 and breast carcinoma: The PI3K/AKT pathway is activated by the production of 3’-phosphorylated phosphoinositides (Fig. 1), and it is an important signaling pathway for MDR in a variety of cancers, such as breast cancer, leukemia, lung cancer, ovarian cancer, hepatocellular carcinoma, and melanoma7–12.